Literature DB >> 22441897

Novel molecular screening approaches in colorectal cancer.

Seth Miller1, Scott Steele.   

Abstract

Traditional methods for colorectal cancer (CRC) screening have reduced rates of malignancy and death; however, low compliance and morbidities associated with invasive techniques have encouraged efforts for establishing equally effective, less invasive novel screening approaches. We review the current state of novel screening approaches in CRC to include CT colonography, fecal DNA, DNA methylation, micro-RNA, and protein and molecular markers.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441897     DOI: 10.1002/jso.21704

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  Overexpressed RACK1 is positively correlated with malignant degree of human colorectal carcinoma.

Authors:  Shaoju Jin; Yishuang Mu; Xiaodong Wang; Zhenru Liu; Lihong Wan; Yao Xiong; Yuanyuan Zhang; Liming Zhou; Li Li
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

2.  Screening or Symptoms? How Do We Detect Colorectal Cancer in an Equal Access Health Care System?

Authors:  Quinton M Hatch; Kevin R Kniery; Eric K Johnson; Shelly A Flores; David L Moeil; John J Thompson; Justin A Maykel; Scott R Steele
Journal:  J Gastrointest Surg       Date:  2015-12-01       Impact factor: 3.452

3.  Discovery of genes from feces correlated with colorectal cancer progression.

Authors:  Chia-Long Lee; Chi-Jung Huang; Shung-Haur Yang; Chun-Chao Chang; Chi-Cheng Huang; Chih-Cheng Chien; Ruey-Neng Yang
Journal:  Oncol Lett       Date:  2016-08-31       Impact factor: 2.967

4.  Differential expression of circulating microRNAs according to severity of colorectal neoplasia.

Authors:  Gloria Y F Ho; Hwa Jin Jung; Robert E Schoen; Tao Wang; Juan Lin; Zev Williams; Joel L Weissfeld; Jung Yoon Park; Olivier Loudig; Yousin Suh
Journal:  Transl Res       Date:  2015-02-23       Impact factor: 7.012

5.  Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer.

Authors:  Hui-Peng Wang; Yang-Yun Wang; Jie Pan; Rong Cen; Yuan-Kun Cai
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 6.  Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.

Authors:  Enikő Orosz; István Ember; Katalin Gombos; László Tóth; Ádám Tarpay; Ákos Pap; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2013-07-19       Impact factor: 3.201

7.  Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms.

Authors:  Federica Domati; Stefania Maffei; Shaniko Kaleci; Carmela Di Gregorio; Monica Pedroni; Luca Roncucci; Piero Benatti; Giulia Magnani; Luigi Marcheselli; Luca Reggiani Bonetti; Francesco Mariani; Antonio Maria Alberti; Valerio Rossi; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2013-08-09       Impact factor: 3.397

8.  Colorectal cancer screening in an equal access healthcare system.

Authors:  Mia Debarros; Scott R Steele
Journal:  J Cancer       Date:  2013-03-20       Impact factor: 4.207

Review 9.  The CpG island methylator phenotype (CIMP) in colorectal cancer.

Authors:  Ehsan Nazemalhosseini Mojarad; Peter Jk Kuppen; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

10.  Discovery and validation of new potential biomarkers for early detection of colon cancer.

Authors:  Xavier Solé; Marta Crous-Bou; David Cordero; David Olivares; Elisabet Guinó; Rebeca Sanz-Pamplona; Francisco Rodriguez-Moranta; Xavier Sanjuan; Javier de Oca; Ramon Salazar; Victor Moreno
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.